Histopathologic correlates of myocardial improvement in patients supported by a left ventricular assist device

被引:0
|
作者
Segura, Ana Maria [1 ]
Frazier, O. H. [2 ]
Demirozu, Zumrut [2 ]
Buja, L. Maximilian [1 ,3 ]
机构
[1] St Lukes Episcopal Hosp, Texas Heart Inst, Dept Cardiovasc Pathol, Houston, TX 77225 USA
[2] St Lukes Episcopal Hosp, Texas Heart Inst, Dept Cardiovasc Transplantat, Houston, TX 77225 USA
[3] Univ Texas Hlth Sci Ctr, Dept Pathol & Lab Med, Houston, TX USA
关键词
Heart-assist device; Hypertrophy; Myocardium; Myocyte; Remodeling; Transplantation; MECHANICAL CIRCULATORY SUPPORT; CARDIAC RECOVERY; HEART-FAILURE; LVAD SUPPORT; CARDIOMYOPATHY; HYPERTROPHY; REGRESSION; FIBROSIS; REVERSAL; BRIDGE;
D O I
10.1016/j.carpath.2010.01.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Left ventricular assist devices unload the failing heart and improve hemodynamic function and tissue architecture. In some patients improvement allows for left ventricular assist device removal. We retrospectively compared histologic features in patients who were weaned off left ventricular assist device support with those who remained on support without evidence of clinical remission. Methods: We graded left ventricular core samples taken at implantation on a scale we designed for evaluating severity and extent of fibrosis and hypertrophy. We correlated the grades with a computerized semiquantitative analysis of picrosirius-red and Masson's trichrome-stained sections. We evaluated interstitial (10x), perivascular (20x), and replacement (4x) fibrosis. Hypertrophy was assessed by myocyte diameter, cytoplasmic area, and nuclear/cytoplasmic ratio. Results: All patients (N=17) underwent left ventricular assist device implantation for heart failure. In eight patients improvement allowed left ventricular assist device removal. The groups did not differ in age (24.1 vs. 25 years, P=.4) or mean time on left ventricular assist device support (506 vs. 414 days, P=.24). All mean measures showed significantly less hypertrophy in the left ventricular assist device-removal group than in the nonremoval group, respectively (cytoplasmic area, 58.00 vs. 77.18 mu m(2), P=.021; myocyte diameter, 20.32 vs. 25.35 mu m, P=.004; nuclear/cytoplasmic ratio, 11.04 vs. 8.69, P=.053). Although not statistically significant, the left ventricular assist device-removal group tended toward less overall fibrosis than the nonremoval group (11.57 vs. 13.24, P=.214). Conclusions: Left ventricular assist device-removal patients had less hypertrophy and fibrosis overall than did nonremoval patients. These findings may help identify patients with a higher probability of left ventricular assist device removal and myocardial recovery. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:139 / 145
页数:7
相关论文
共 50 条
  • [31] In Patients Supported by a Left Ventricular Assist Device, Bi-Ventricular Pacing does not Offer Hemodynamic Improvement over Right Ventricular Pacing
    Inampudi, Chakradhari
    Johnson, Frances
    Tahir, Rizwan
    Tandon, Rudhir
    Iqbal, Omer J.
    Emerenini, Uzodinma
    Giudici, Michael C.
    Cotarlan, Vlad
    [J]. CIRCULATION, 2015, 132
  • [32] SPHINGOLIPIDS AS POTENTIAL SURROGATES OF MYOCARDIAL RECOVERY IN LEFT VENTRICULAR ASSIST DEVICE PATIENTS
    Hamouche, Rana
    Tatum, Sean
    Dranow, Elizabeth
    Kyriakopoulos, Christos P.
    Shankar, Thirupura Sundari
    Visker, Joseph
    Ling, Jing
    Sideris, Konstantinos
    Selzman, Craig H.
    Kfoury, Abdallah G.
    Stehlik, Josef
    Alharethi, Rami
    Fang, James C.
    Navankasattusas, Sutip
    Holland, William
    Summers, Scott
    Drakos, Stavros George
    Tseliou, Eleni
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 297 - 297
  • [33] Myocardial Recovery Profile in Patients Following Left Ventricular Assist Device Explantation
    Crespo, R.
    Weaver, C.
    Bennett, M.
    Sun, B.
    Eckman, P.
    Samara, M.
    Hryniewicz, K.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S443 - S443
  • [34] Improved quality of life and functional improvement in patients supported with the HeartMate II, an axial flow left ventricular assist device
    Gemmato, C.
    Radovancevic, B.
    Carranza, S.
    Radovancevic, K.
    Delgado, R. M., III
    Gregoric, I.
    Frazier, O. H.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (02): : S162 - S162
  • [35] Correlation of Fibrosis and Hypertrophy with Myocardial Improvement during Left Ventricular Assist Device (LVAD) Support
    Segura, A. M.
    Barton, P.
    George, R.
    Khaghani, A.
    Buja, L. M.
    Frazier, O. H.
    Birks, E.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S77 - S77
  • [36] Medical Management of Patients With a Left Ventricular Assist Device for the Non-Left Ventricular Assist Device Specialist
    DeVore, Adam D.
    Patel, Priyesh A.
    Patel, Chetan B.
    [J]. JACC-HEART FAILURE, 2017, 5 (09) : 621 - 631
  • [37] Left ventricular assist device implantation in patients with left ventricular thrombus
    Dogan, Gunes
    Mariani, Silvia
    Hanke, Jasmin S.
    Deniz, Ezin
    Merzah, Ali
    Li, Tong
    Haverich, Axel
    Schmitto, Jan D.
    [J]. ARTIFICIAL ORGANS, 2021, 45 (09) : 1006 - 1013
  • [38] Chronological changes and correlates of loop diuretic dose in left ventricular assist device patients
    Kido, Kazuhiko
    Charnigo, Richard
    George, Bennet
    Macaulay, Tracy
    Brouse, Sara
    Guglin, Maya
    [J]. PHARMACOTHERAPY, 2016, 36 (12): : E214 - E214
  • [39] Chronologic Changes and Correlates of Loop Diuretic Dose in Patients with Left Ventricular Assist Device
    Kido, Kazuhiko
    George, Bennet
    Charnigo, Richard J.
    Macaulay, Tracy E.
    Brouse, Sara D.
    Guglin, Maya
    [J]. ASAIO JOURNAL, 2017, 63 (06) : 774 - 780
  • [40] The impact of ventricular arrhythmias in ventricular assist device supported patients
    Gkouziouta, A.
    Kogerakis, N.
    Miliopoulos, D.
    Koutsiari, K.
    Poulos, G.
    Maounis, T. H.
    Kostopoulou, A.
    Livanis, E.
    Theodorakis, G.
    Adamopoulos, S.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 695 - 696